Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.348
Companies that carry out R&D in Biotechnology	Main	661
Companies that carry out R&D in Biotechnology	Secondary dwellings	188
Companies that carry out R&D in Biotechnology	Tool	500
%Companies according to biotechnology used: Genetic code	Total	31
%Companies according to biotechnology used: Genetic code	Main	40,3
%Companies according to biotechnology used: Genetic code	Secondary dwellings	25,2
%Companies according to biotechnology used: Genetic code	Tool	21
%Companies according to biotechnology used: Functional units	Total	38,4
%Companies according to biotechnology used: Functional units	Main	45,9
%Companies according to biotechnology used: Functional units	Secondary dwellings	37,6
%Companies according to biotechnology used: Functional units	Tool	28,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	21,7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	27,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	15,9
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	16,5
%Companies according to biotechnology used: Bioprocesses	Total	50,3
%Companies according to biotechnology used: Bioprocesses	Main	40,9
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	53,3
%Companies according to biotechnology used: Bioprocesses	Tool	61,7
%Companies according to biotechnology used: Sub-cellular organisms	Total	8,2
%Companies according to biotechnology used: Sub-cellular organisms	Main	12,1
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	3,3
%Companies according to biotechnology used: Sub-cellular organisms	Tool	5
%Companies according to biotechnology used: Bio-computing	Total	24,1
%Companies according to biotechnology used: Bio-computing	Main	33,8
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	20,2
%Companies according to biotechnology used: Bio-computing	Tool	12,9
%Companies according to biotechnology used: Nanobiotechnology	Total	11,8
%Companies according to biotechnology used: Nanobiotechnology	Main	15,9
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	14
%Companies according to biotechnology used: Nanobiotechnology	Tool	5,4
%Companies according to biotechnology used: Other	Total	16,4
%Companies according to biotechnology used: Other	Main	18,4
%Companies according to biotechnology used: Other	Secondary dwellings	20,3
%Companies according to biotechnology used: Other	Tool	12,3
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	45,8
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	64,5
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	32,2
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	26,3
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	15,3
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	17,2
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	14,5
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	12,9
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	31,5
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	21,1
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	34,9
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	44,1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	23,7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	19,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	32,9
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	25,2
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	15,5
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	14,1
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	25,4
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	13,7
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	13,4
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	14,3
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	19,1
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	10,1
Personnel in R&D in biotechnology (no. of persons)	Total	15.744
Personnel in R&D in biotechnology (no. of persons)	Main	8.573
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.786
Personnel in R&D in biotechnology (no. of persons)	Tool	5.385
Personnel in R&D in biotechnology (no. of persons): Research personnel	Total	8.380
Personnel in R&D in biotechnology (no. of persons): Research personnel	Main	5.028
Personnel in R&D in biotechnology (no. of persons): Research personnel	Secondary dwellings	952
Personnel in R&D in biotechnology (no. of persons): Research personnel	Tool	2.400
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Total	7.364
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Main	3.545
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Secondary dwellings	834
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel	Tool	2.985
Personnel in R&D in biotechnology (no. of persons). Women	Total	8.725
Personnel in R&D in biotechnology (no. of persons). Women	Main	4.985
Personnel in R&D in biotechnology (no. of persons). Women	Secondary dwellings	952
Personnel in R&D in biotechnology (no. of persons). Women	Tool	2.788
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Total	4.521
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Main	2.794
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Secondary dwellings	504
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel	Tool	1.223
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Total	4.204
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Main	2.191
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Secondary dwellings	448
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel	Tool	1.565
Personnel in R&D in biotechnology (FTE)	Total	11.523,2
Personnel in R&D in biotechnology (FTE)	Main	6.809,8
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	1.008,1
Personnel in R&D in biotechnology (FTE)	Tool	3.705,3
Personnel in R&D in biotechnology (FTE): Research personnel	Total	6.341,6
Personnel in R&D in biotechnology (FTE): Research personnel	Main	4.061,4
Personnel in R&D in biotechnology (FTE): Research personnel	Secondary dwellings	628,5
Personnel in R&D in biotechnology (FTE): Research personnel	Tool	1.651,7
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Total	5.181,6
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Main	2.748,4
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Secondary dwellings	379,7
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel	Tool	2.053,6
Personnel in R&D in biotechnology (FTE). Women	Total	6.552,7
Personnel in R&D in biotechnology (FTE). Women	Main	4.019,9
Personnel in R&D in biotechnology (FTE). Women	Secondary dwellings	569,1
Personnel in R&D in biotechnology (FTE). Women	Tool	1.963,7
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Total	3.464,4
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Main	2.258,6
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Secondary dwellings	349,8
Personnel in R&D in biotechnology (FTE). Women: Research personnel	Tool	855,9
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Total	3.088,3
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Main	1.761,3
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Secondary dwellings	219,3
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel	Tool	1.107,7
Internal expenditure on R&D (thousands of euros)	Total	1.037.887
Internal expenditure on R&D (thousands of euros)	Main	643.053
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	81.049
Internal expenditure on R&D (thousands of euros)	Tool	313.785
1) By nature of the expense: Current expenses	Total	939.471
1) By nature of the expense: Current expenses	Main	569.179
1) By nature of the expense: Current expenses	Secondary dwellings	76.172
1) By nature of the expense: Current expenses	Tool	294.120
1.1) Remuneration to research personnel	Total	321.525
1.1) Remuneration to research personnel	Main	206.505
1.1) Remuneration to research personnel	Secondary dwellings	32.639
1.1) Remuneration to research personnel	Tool	82.382
1.2) Remuneration to technicians and auxiliary personnel	Total	194.656
1.2) Remuneration to technicians and auxiliary personnel	Main	105.018
1.2) Remuneration to technicians and auxiliary personnel	Secondary dwellings	12.981
1.2) Remuneration to technicians and auxiliary personnel	Tool	76.658
1.3) Other current expenses	Total	423.290
1.3) Other current expenses	Main	257.656
1.3) Other current expenses	Secondary dwellings	30.553
1.3) Other current expenses	Tool	135.081
2) By nature of the expense: Capital expenses	Total	98.416
2) By nature of the expense: Capital expenses	Main	73.874
2) By nature of the expense: Capital expenses	Secondary dwellings	4.877
2) By nature of the expense: Capital expenses	Tool	19.664
2.1) Land and buildings	Total	10.150
2.1) Land and buildings	Main	7.449
2.1) Land and buildings	Secondary dwellings	600
2.1) Land and buildings	Tool	2.102
2.2) Equipment and instruments	Total	72.538
2.2) Equipment and instruments	Main	53.214
2.2) Equipment and instruments	Secondary dwellings	3.495
2.2) Equipment and instruments	Tool	15.828
2.3) Acquisition of specific R+D software	Total	5.713
2.3) Acquisition of specific R+D software	Main	4.293
2.3) Acquisition of specific R+D software	Secondary dwellings	369
2.3) Acquisition of specific R+D software	Tool	1.051
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	10.015
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	8.918
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	413
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	684
1.1) By origin of the funds: Own funds	Total	711.037
1.1) By origin of the funds: Own funds	Main	412.945
1.1) By origin of the funds: Own funds	Secondary dwellings	55.579
1.1) By origin of the funds: Own funds	Tool	242.513
1.2) By origin of the funds: From companies	Total	121.595
1.2) By origin of the funds: From companies	Main	82.588
1.2) By origin of the funds: From companies	Secondary dwellings	8.576
1.2) By origin of the funds: From companies	Tool	30.431
1.3) By origin of the funds: Public Administration funds	Total	107.422
1.3) By origin of the funds: Public Administration funds	Main	66.483
1.3) By origin of the funds: Public Administration funds	Secondary dwellings	11.401
1.3) By origin of the funds: Public Administration funds	Tool	29.539
1.4) By origin of the funds: From Universities	Total	192
1.4) By origin of the funds: From Universities	Main	68
1.4) By origin of the funds: From Universities	Secondary dwellings	14
1.4) By origin of the funds: From Universities	Tool	111
1.5) By origin of the funds: From non profit private institutions	Total	10.756
1.5) By origin of the funds: From non profit private institutions	Main	9.444
1.5) By origin of the funds: From non profit private institutions	Secondary dwellings	0
1.5) By origin of the funds: From non profit private institutions	Tool	1.312
1.6) By origin of the funds: Foreign funds	Total	86.884
1.6) By origin of the funds: Foreign funds	Main	71.524
1.6) By origin of the funds: Foreign funds	Secondary dwellings	5.480
1.6) By origin of the funds: Foreign funds	Tool	9.880
Purchase of R&D services in biotechnology (thousands of euros)	Total	145.440
Purchase of R&D services in biotechnology (thousands of euros)	Main	107.282
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	14.145
Purchase of R&D services in biotechnology (thousands of euros)	Tool	24.013
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	95.870
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	75.671
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	12.772
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	7.428
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	49.570
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	31.611
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	1.374
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	16.585
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	39,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	48,6
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	37,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	28,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	12,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	11,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	15,6
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	12,7
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	18,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	20,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	20,6
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	14,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	11,2
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	10,5
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	15,2
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	10,7
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Total	15,6
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Secondary dwellings	25,4
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets	Tool	11,3
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Total	16,5
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Main	19
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Secondary dwellings	21,4
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels	Tool	11,5
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Total	16,1
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Main	16,4
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Secondary dwellings	23,8
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception	Tool	12,7
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	40
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	47,3
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	42,8
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	29,4
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Total	53,9
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Main	62,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Secondary dwellings	54,5
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost	Tool	41,9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	21,5
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	23,6
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	26,1
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	16,9
% Companies with income of an international origin related to biotechnological activities	Total	22,2
% Companies with income of an international origin related to biotechnological activities	Main	29,9
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	15,4
% Companies with income of an international origin related to biotechnological activities	Tool	14,7
% Turnover representing income of an international origin related to biotechnological activities	Total	1,9
% Turnover representing income of an international origin related to biotechnological activities	Main	13,4
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0,1
% Turnover representing income of an international origin related to biotechnological activities	Tool	1,5
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	65,5
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	67,7
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	57
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	60,1
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	34,5
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	32,3
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	43
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	39,9
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	86,3
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	82,7
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	91,3
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	96,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	12,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	16,4
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	1,2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	0,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1,1
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	0,8
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	7,5
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	1,3
% Income of an international origin related with activities according to the classification: Other	Total	0,4
% Income of an international origin related with activities according to the classification: Other	Main	0,1
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0
% Income of an international origin related with activities according to the classification: Other	Tool	1,3